Conclusive evidence of endotoxaemia in biliary obstruction

Gut

Volumn 42, Issue 2, 1998, Pages 293-299

  Clements, W D B ^a,c   Erwin, P ^a   McCaigue, M D ^a   Halliday, I ^a   Barclay, G R ^b   Rowlands, B J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b Regional Blood Transfusion Service   (United Kingdom)

^c Institute of Clinical Sciences B   (United Kingdom)

Author keywords

Biliary obstruction; EndoCab assay; Endotoxaemia

Indexed keywords

ENDOTOXIN; TETANUS TOXIN;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGENICITY; ARTICLE; BILE DUCT OBSTRUCTION; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; NONHUMAN; PRIORITY JOURNAL; RAT; TOXIN ANALYSIS;

EID: 0031923964     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.42.2.293     Document Type: Article

References (63)

1. Greig JD, Krukowski ZH, Matheson NA. Surgical morbidity and mortality in one hundred and twenty nine patients with obstructive jaundice. Br J Surg 1988;75:216 9.
2. Lai ECS, Chu KM, Lo C-Y, et al. Surgery for malignant obstructive jaundice: analysis of mortality. Surgery 1992; 112:891 6.
3. Sikora SS, Kapoor R, Pradeep R, Kapoor VK, Saxena R, Kaushik SP. Palliative surgical treatment of malignant obstructive jaundice. Eur J Surg Oncol 1994;20:580-4.
4. Armstrong CP, Dixon JM, Taylor TV, Davies GC. Surgical experience of deeply jaundiced patients with bile duct obstruction. Br J. Surg 1984;71:234 8.
5. Bakkevold KE, Kampstead B. Morbidity and mortality after radical and palliative pancreatic surgery. Risk factors influencing short term results. Ann Surg 1993;217:356 68.
6. Trede M, Schwall G. The complications of pancreatectomy. Ann Surg 1988;207:39 47.
7. Blamey SL, Fearon KCH, Gilmour WH, Osbourne DH, Carter DC. Prediction of risk in biliary surgery. Br J Surg 1983;70:535 8.
8. Pitt HA, Cameron JL, Postier RG, Gadaez TR. Factors affecting mortality in biliary tract surgery. Am J Surg 1981; 141:66 72.
9. Su CH, Pleng FK, Lui WY. Factors affecting morbidity and mortality in biliary tract surgery. World J Surg 1992;16: 536-40.
10. Wardle EN, Wright NA. Endotoxin and acute renal failure associated with obstructive jaundice. BMJ 1970;4:472 4.
11. Bailey ME. Endotoxin, bile salts and renal function in obstructive jaundice. Br J Surg 1976;66:392 7.
12. Hunt DR. The identification of risk factors and their application to the management of obstructive jaundice. Aust N Z J Surg 1980;50:476 80.
13. Clements WDB, Halliday MI, McCaigue MD, Barclay RG, Rowlands BJ. Effects of extrahepatic obstructive jaundice on Kupffer cell clearance capacity. Arch Surg 1993;128: 200 5.
14. Diamond T, Dolan S, Thompson RLE, Rowlands BJ. Development and reversal of endotoxaemia and endotoxin related death in obstructive jaundice. Surgery 1990;108: 370 5.
15. Roughneen PT, Kumar SC, Pellis NR, Rowlands BJ. Endotoxaemia and cholestasis. Surg Gynaecol Obster 1988;167: 205 10.
16. Greve JW, Gouma DJ, Soeters PB, Buurman WA. Suppression of cellular immunity in obstructive jaundice is caused by endotoxin. A study with germfree rats. Gastroenterology 1990;98:478 85.
17. Scott BB, Barclay RG. Endotoxin-polymyxin complexes in an improved enzyme-linked immunosorbent assay tor IgG antibodies in blood donor sera to gram-negative endotoxin core glycolipids. Vox Sang 1987;52:272 80.
18. Lee E. The effect of obstructive jaundice on the migration of reticuloendothelial cells and fibroblasts into early experimental granulomata. Br J Surg 1972;59:875 7.
19. Diamond T, Rowlands BJ. Endotoxaemia in obstructive jaundice. HPB Surg 1991;4:81 94.
20. Wells CL, Maddaus MA, Simmons RL. Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis 1988;10:958 79.
21. Deitch EA, Sittig K, Li M, Berg R, Specian RD. Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg 1990;159:79 84.
22. Ding JW, Andersson R, Soltesz V, Willen R, Bengmark S. Obstructive jaundice impairs reticuloendothelial function and promotes bacterial translocation in the rat. J Surg Res 1994;67:238-46.
23. Clements WDB, Parks R, Erwin P, Halliday MI, Barr J, Rowlands BJ. Role of the gut in the pathophysiology of extrahepatic biliary obstruction. Gut 1996;39:587 93.
24. Bradfield JWB. Control of spillover: the importance of Kupffer cell function in clinical medicine. Lancet 1974;ii: 883 6.
25. Cardoso V, Pimenta A, Correia da Fonesca J, Rodrigues JS, Machado MJ. The effect of cholestasis on hepatic clearance of bacteria. World J Surg 1982;6:330-4.
26. Vane DW, Redlich P, Weber T, Leapman S, Siddiqui AR, Grosfield JL. Impaired immune function in obstructive jaundice. J Surg Res 1988;45:287 93.
27. Katz S, Grosfeld JC, Gross K, et al. Impaired bacterial clearance and trapping in obstructive jaundice. Ann Surg 1984; 199:14-20.
28. Bemelmans MHA, Greve JW, Gouma DT, Buurmann WA. Cytokines, tumour necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology 1992; 15:1132-6.
29. Clements WDB, Crockard A, Hoper M, Rowlands BJ. Major histocompatibility class II antigen expression in experimental biliary obstruction. Br J Surg 1994;81:757-8.
30. Scott-Conner CEH, Grogan JB. The pathophysiology of biliary obstruction and its effect on phagocytic and immune function. J Surg Res 1994;57:316-36.
31. Kimmings AN, van Deventer SJH, Obertop H, Rauws EAJ, Gouma DJ. Inflammatory and immunologic effects of obstructive jaundice: pathogenesis and treatment. Am J Surg 1995;181:567-81.
32. Matsnura K, Ishida T, Seguchi M, Higuchi Y, Akizuki S, Yamamoto S. Upregulation of mouse CD14 expression in Kupffer cells by lipopolysaccharide. J Exp Med 1994;179: 1671-6.
33. Tracy TF, Fox ES. CD14-lipopolysaccharaide receptor activity in hepatic macrophages after cholestatic liver injury. Surgery 1995;118:371-7.
34. Fletcher MS, Westwick J, Kakkar VV. Endotoxin, prostaglandins and renal fibrin deposition in obstructive jaundice. Br J Surg 1982;69:625-9.
35. Dixon JM, Armstrong CP, Duffy SW, Elton RA, Davies GC. Upper gastrointestinal bleeding. A significant complication after surgery for relief of obstructive jaundice. Ann Surg 1984;199:271-5.
36. Wardle EN. Fibrinogen in liver disease. Arch Surg 1974;109: 741-6.
37. Arnaud JP, Humbert W, Eloy MR, Adloff M. Effect of obstructive jaundice on wound healing. An experimental study in rats. Am J Surg 1988;141:593-696.
38. Clements WDB, Diamond T, McCrory D, Rowlands BJ. Biliary drainage in obstructive jaundice - experimental and clinical aspects. Br J Surg 1993;80:834-42.
39. Kocsar LT, Bertok L, Varteresz V. Effect of bile acids on intestinal absorption of endotoxin in rats. J Bacteriol 1969; 100:220-3.
40. Cahill CJ. Prevention of postoperative renal failure in patients with obstructive jaundice - the role of bile salts. Br J Surg 1993;70:690-6.
41. Thompson JN, Cohen J, Blenkarn JI, McConnell JS, Barr J, Blumgart LH. A randomised clinical trial of ursodeoxycholic acid in obstructive jaundice. Br J Surg 1986;73:634-6.
42. Gawley WF, Gorey TF, Johnson AH, et al. The effect of oral bile salts on serum endotoxin and renal function in obstructive jaundice. Br J Surg 1988;76:600-6.
43. Hunt DR, Allison MEM, Prentice CRM, et al. Endotoxemia, disturbance of coagulation and obstructive jaundice. Am J Surg 1982;144:325-9.
44. Liehr H, English G, Rasenack U. Lactulose - a drug with anti-endotoxin effect. Hepatogastroenterology 1980;27:356-60.
45. Pain JA, Bailey ME. Experimental and clinical study of lactulose in obstructive jaundice. Br J Surg 1986;73:775-8.
46. Bang FB. A bacterial disease of Limulus polyphemus. Bulletin of Johns Hopkins Hospital 1956;98:325-50.
47. Iwanga S, Morita T, Harada T, et al. Chromogenic substrates for horseshoe crab clotting enzyme. Its application for the assay of bacterial endotoxins. Haemostasis 1978;7:183-8.
48. Cohen J, McConnell JS. Observations on the measurement and evaluation of endotoxaemia by a quantitative Limulus lysate microassay. J Infect Dis 1984;150:916-24.
49. Jacob AL, Goldberg BS, Bloom N. Endotoxin and bacteria in portal blood. Gastroenterology 1977;72:1268-70.
50. Scarnes RC. The inactivation of endotoxin after interaction with certain proteins of normal serum. Ann NY Acad Sci 1966;133:644-62.
51. Fink PC, Lehr L, Urbaschek RM. Limulus amoebocyte lysate test for endotoxaemia. Investigations with a sensitive spectrophotometric assay. Klin Wochenschr 1981;59:213-8.
52. Sturk A, van Deventer SJH, ten Cate, Buller HR. In: van Deventer SJH, MD thesis, University of Amsterdam, 1987: 53 73.
53. Thomas LLM, Sturk A, Kahle LH, ten Cate JW. Quantitative endotoxin determination in blood with a chromogenic substrate. Clin Chem Acta 1981;116:62-8.
54. Wright SD. Multiple receptors for endotoxin. Curr Opin Immunol 1991;3:83-90.
55. Barclay GR. Endogenous endotoxin-core antibody (Endo-CAb) as a marker of endotoxin exposure and a prognostic indicator: a review. In: Bacterial lipopolysaccharides: from genes to therapy. Wiley-Liss, 1996:263-72.
56. Windsor JA, Fearon KCH, Ross JA, et al. Role of serum endotoxin core antibody in predicting the development of multiple organ failure in acute pancreatitis. Br J Surg 1993; 80:1042-6.
57. Gardiner KR, Halliday MI, Barclay GR, et al. Significance of systemic endotoxaemia in inflammatory bowel disease. Gut 1995;36:897-901.
58. Goldie AS, Fearon KCH, Ross JA, et al. Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. JAMA 1995;274:172 7.
59. Oriishi T, Sata M, Toyonaga A, Sasaki E, Tanikawa K. Evaluation of intestinal permeability in patients with inflammatory bowel disease using lactulose and measuring antibodies to lipid A. Gut 1995;36:891-6.
60. McCrory DMcC, Halliday MI, McCaigue M, Barclay GR, Rowlands BJ. Preoperative rise and postoperative consumption of antiendotoxin antibodies in jaundiced patients. Br J Surg 1992;79:1241.
61. Barclay GR, Scott BB, Wright IH, Rogers PN, Smith DGE, Poxton IR. Changes in anti-endotoxin IgG antibody and endotoxaemia in three cases of Gram-negative septic shock. Circ Shock 1989;29:93-106.
62. Curley PJ, McMahon MJ, Lancaster F, et al. Reduction in circulating levels of CD4-positive lymphocytes in acute pancreatitis: relationship to endotoxin, interleukin 6 and disease severity. Br J Surg 1993;80:1312-5.
63. Mythen MG, Barclay GR, Purdy G, et al. The role of endotoxin immunity, neutrophil degranulation and contact activation in the pathogenesis of post-operative organ dysfunction. Blood Coagul Fibrinolysis 1993;4:999-1005.